Should You Buy Nvidia Before Feb. 25? Here's What History Says.

Nvidia has surged more than 800% over the past three years as it solidified leadership in AI chips, posting consecutive quarters of outsized revenue growth and gross margins above 70%. Fiscal Q4 and full-year 2026 results are due Feb. 25 after the close; while partner TSMC recently beat estimates, Nvidia’s stock has shown short-term weakness around earnings (down in 6 of the last 11 post-report weeks and up in only 1 of the last 6), suggesting strong fundamentals but recurring post-earnings volatility and supporting a long-term buy-over-timing approach.

Analysis

Market structure: Nvidia (NVDA) is the clear winner — >800% 3-year return, sustained >70% gross margins and platform lock-in mean disproportionate pricing power for datacenter GPUs; cloud providers (AMZN/GOOGL/MSFT) and advanced foundries (TSM) also benefit from capex but capture less margin. Competitors can grow but likely cede share in high-end training workloads, keeping ASPs elevated and leading to a supply-tight environment for leading-node GPUs that supports elevated semiconductor equipment and memory demand. Cross-asset: rising AI capex is reflationary — modest upward pressure on IG spreads and copper; expect elevated NVDA options IV around Feb 25 and potential USD strength if tech flows rotate into mega-caps.

Risk assessment: Tail risks include (1) renewed US/China export controls on advanced GPUs or TSMC tooling within 60–180 days, (2) an abrupt enterprise spending pause if macro weakens causing >20% downdraft in NVDA revenue guidance, and (3) execution issues at TSM (yield/capacity) that delay product cadence. Immediate (days): earnings reaction volatility (historically negative week after earnings 6/11 times). Short-term (weeks–months): guidance swings and capex updates matter. Long-term (years): secular AI adoption supports durable TAM but hinges on supply (TSM capacity) and software differentiation.

Trade implications: Favor a staged accumulation of NVDA rather than front-running Feb 25 — use delta-based option selling to monetize rich IV and reduce basis. Consider relative-value exposure to NVDA’s software/IP premium versus foundry cyclicality (long NVDA, partial hedge to foundry/semicap). Rotate 3–6% portfolio weight from generic high-multiple AI names into concentrated NVDA exposure while holding 5–10% cash for drawdowns.

Contrarian angles: Consensus underestimates short-term downside around earnings — past pattern shows post-earnings pullbacks despite beats; that creates tactical buying windows. The market may be underpricing the risk of supply concentration at TSM impacting delivery timing — a scenario that would compress short-term multiples but improve long-term pricing power for NVDA if scarcity persists. Historical parallel: platform winners (MSFT in enterprise client-server era) saw volatile quarters yet multi-year dominance; treat NVDA similarly and avoid linear extrapolation of next-quarter reactions.

Key Decisions for Investors

• Establish an initial 2–3% long position in NVDA within 2 weeks after the Feb 25 earnings print; increase to 5–7% if NVDA trades down 8–12% from the pre-earnings close within 30 calendar days (buy-the-dip scaling).
• Sell cash-secured NVDA puts sized to desired exposure: target 30-delta, 45-day expiries (post-earnings IV), collect premium to achieve an annualized return target >20% if assigned; if put-to, plan to hold for 12–24 months.
• Initiate a pair trade: long NVDA (3% portfolio) and hedge with a 50–66% notional short to TSM or SMH (2% portfolio) to express NVDA's software/IP margin premium versus foundry cyclicality; use 15% stop-loss on either leg and rebalance quarterly.
• Trim 15–25% of positions in non-NVDA high-multiple 'AI play' names (broad small-cap AI/theme ETFs or individual overlevered names) and redeploy into NVDA/TSM/IG bonds if NVDA/AI market cap drops >15% in a 10-trading-day window to rebalance concentration risk.
• Monitor two hard catalysts over the next 60 days before adding >1% more exposure: (A) TSMC capacity/capex commentary and (B) any US export-control announcements — if either signals material constraint or restriction, pause additions and reassess sizing within 5 trading days.